153 The development of a cell bank system for preclinical evaluation of an allogeneic cartilage repair biologic

Objectives/Goals: The number of FDA-approved cellular and gene therapy products has doubled from 23 in 2022 to 46 in 2025. For allogeneic cell therapies, cell banks are essential both during preclinical development and manufacturing clinical products. The objective of this study is to establish a ce...

Full description

Bibliographic Details
Published in:Journal of Clinical and Translational Science
Main Authors: Rachel Nordberg, Ryan P. Donahue, M. Gabriela Espinosa, Evelia Y. Salinas, Jerry C. Hu, Kyriacos A. Athanasiou
Format: Article
Language:English
Published: Cambridge University Press 2026-04-01
Online Access:https://www.cambridge.org/core/product/identifier/S205986612610363X/type/journal_article